Mice injected intravenously with a commercially available extract of Coxiella burnetii prepared for use as the antigen in the complement fixation diagnostic test for Q fever were subsequently resistant to infection with Babesia microti, Babesia rodhaini, and Plasmodium vinckei petteri. The parasites appeared to die inside circulating erythrocytes. Protection was unaffected by exposing the pretreated mice to 900 rads on the day before they were infected. To explain these findings, it is postulated that pretreatment with Coxiella extract protects by potentiating the interferon-inducing capacity of the challenge dose of protozoa, which perhaps leads to enhanced activity of natural killer cells. Tumor necrosis factor also warrants investigation.
We have previously presented evidence that BCG (5) and killed Corynebacterium parvum (6) protect mice from subsequent infection with Babesia spp. and certain Plasmodium spp. Brucella abortus S19 also protects mice against both Babesia microti (19) and Plasmodium vinckei (J. Harvey, A. Kaplun, and I. A. Clark, unpublished data). As well as causing splenomegaly and inducing granulomatous reactions, these agents suppress certain experimental tumors (17, 38, 54) and protect against apparently unrelated bacteria (2, 11, 34) . Arguments have been presented that the protection which these agents afford against hemoprotozoa is not due to shared antigens, enhanced production of specific antibody, or phagocytosis, but has its basis in the nonspecific immunity expressed during infection with these bacteria (6, 8) .
Because Coxiella burnetii also shares these characteristics (26, 27, 32, 43) , I Fig. 1 and 2 , control groups). Neither extract visibly affected the mice, although on histology the group injected with Coxiella extract showed granulomas which were the same as those previously reported during Q fever (43) . These lesions were particularly evident in the liver and splenic red pulp.
To establish the minimum effective dose of Coxiella extract, a range of doses between 5 and 100 fl was given to additional groups of five mice each. After 3 weeks these also received 106 B. microti. As Fig. 1 shows, protection was appreciable even in the mice given 5 ul, and it was greater with higher doses. Very few parasites were detected in smears from those given 20 1l of extract, and only a few isolated sightings were made in smears from mice given 50 or 100 ,ul. No parasites were seen after the 50-,il group was again challenged after 24 weeks.
(ii) Time interval between Coxiella extract and B. microti. Groups of five mice each were infected with 106 B. microti at various times after they had received 50 ILI of Coxiella extract. Figure 2 shows the results of the shorterterm experiments, when the interval was 0, 3, or 7 days. When either 8 or 16 weeks had elapsed before the mice were infected, no parasites were subsequently detected. Thus, the longer the interval between injection of Coxiella extract and subsequent infection, the more effectively the parasite was suppressed. Also, when the extract was given 7 days after the infection had been initiated but was not yet patent, it did not diminish the ensuing parasitemia (Fig. 2) .
(iii) Intra-erythrocytic death ofparasites. on October 26, 2017 by guest http://iai.asm.org/ Downloaded from parvum (6), or B. abortus S19 (19) , the inclusion bodies shown to be degenerate intra-erythrocytic parasites (7) were present in erythrocytes of the protected mice in these experiments. The dead parasites had the same appearance and were as common as those previously found by light microscopy (5) (6) (7) 19 ) and electron microscopy (5, 7). Again, parasites could not be detected in macrophages on impression smears from spleens and livers of protected mice.
(iv) Protection after irradiation. Protection that is achieved by the death of the infectious agent within circulating erythrocytes is presumably mediated by a soluble factor. The possibility that this factor was antibody specific for parasite antigens was therefore investigated.
In two experiments 10 mice injected with 200 pl of Coxiella extract 4 weeks earlier and 10 controls were infected with 109 B. microti. One-half of each group of 10 had been exposed to 900 rads 24 h previously. As Fig. 3 shows, this dose of irradiation, given when it could be expected to affect profoundly the production of antibody specific for B. microti (53), did not affect the course of protection. In addition, parasitemias in the pretreated groups fell behind those of the controls within 24 h of infection, too soon for appreciable production of specific antibody.
B. rodhainiL Because one B. rodhaini is invariably fatal to unprotected mice, this parasite was used as a more rigorous test of the efficacy of Coxiella extract against Babesia spp. in this host. Six mice were injected with 200 pl of Coxiella extract. After 2 weeks, these mice and six controls received 106 B. rodhaini. As Fig. 4 shows, the controls died on day 8 or 9, whereas the pretreated mice all survived, having experienced only low parasitemias. In view ofthe effect of a longer time interval between pretreatment and infection on the degree of protection against B. microti (Fig. 2) (Fig. 6) . As in mice protected with C. parvum (6) , dead parasites were present in circulating erythrocytes as the parasitemias decreased in protected mice.
Hyperreactivity to endotoxin. Guinea pigs infected with C. burnetii are hyperreactive to injection with bacterial endotoxin (44) . To ascertain whether this extends to mice and whether it could be induced with the Coxiella extract used in these experiments, mice pretreated with extract were injected with several doses of E. coli endotoxin. The pretreated mice were much more sensitive to this material than were normal mice (Table 1) .
DISCUSSION
Previous reports have referred to the activity of C. burnetii against Brucella suis in vivo (32) and to the in vitro suppression of Listeria monocytogenes by supernatants from macrophages VOL. 24 previously infected in vivo with C. burnetii (26) . Intralesional injection of killed C. burnetii also causes tumor regression (27) . This appears to be the first example of C. burnetii or an extract derived from this organism protecting against a protozoan parasite. The characteristics of this protection seem very much to parallel those we have previously described in mice infected with BCG (5, 8) or pretreated with killed C. parvum (6) . In particular, the effect is radioresistant (Fig. 3 and 6) ; therefore, it is evidently not caused by enhanced production of specific antibody. This type of antiprotozoal activity is possessed not only by the rickettsial extract described in this paper, but also by three genera of bacteria (5, 6, 19) (25) and other interferon inducers have some activity against hemoprotozoa (3, 24) . It is unlikely that the mechanism of the protection induced by Coxiella extract is this simple, however, because its kinetics are much different (weeks) than those of the appearance of interferon in mice injected with C. burnetii (hours). The protective effect of BCG (5), C. parvum (6) , and B. abortus S19 (19) against Babesia spp. also outlasts the ability of these bacteria or their extracts to induce detectable interferon (30, 33, 58) .
Nevertheless, it is still conceivable that an interferon could be mediating the observed protection. As well as protecting mice against these parasites, BCG (52), C. parvum (4), B. abortus S19 (1), Eperythrozoon coccoides (15) , and C. burnetii (Table 1 and reference 44) all enhance the responsiveness of mice to the lethal effects of bacterial endotoxin. With at least BCG (59) and E. coccoides (14) this hyperreactivity includes an increased efficiency of interferon induction by endotoxin. Plasmodium sp. can induce interferon (21) and has been reported to contain material functionally similar to an endotoxin (39) . Likewise, a lipopolysaccharide has recently been isolated from Trypanosoma cruzi (28), a recognized interferon inducer (46) which BCG also protects against (40). Thus, if the increased efficiency of interferon induction by endotoxin which occurs in mice pretreated with BCG (59) and E. coccoides (14) proves to extend to C. parvum, B. abortus, and C. burnetii (as does the hyperreactivity to other effects of endotoxin), pretreatment with these agents may protect by potentiating the interferon-inducing capacity of the challenge dose of protozoa. The maintenance of protection in irradiated mice ( Fig. 3 and 6) is consistent with the radioresistance of induction of interferon by endotoxin (9) .
If interferon is involved in protection against hemoprotozoa by BCG, C. parvum, B. abortus, E. coccoides, and C. burnetii extract, a direct action on deoxyribonucleic acid synthesis is an obvious possibility (31) . However, in view of recent evidence that interferon inducers or interferon may be active against tumors because they augment natural killer (NK) cell activity (37, 13) and our previous evidence that the pro- tective effects of BCG and C. parvum against B. microti, P. vinckei, and tumors are remarkably similar (7), NK cells clearly warrant serious consideration in the protection described in this paper. Many observations are consistent with this. Corticosteroids suppress both NK cells (35) and protection against hemoprotozoa (8) , and the spleen has a central role in each phenomenon (8, 29) . As well as protecting mice against P. vinckei and B. microti, BCG and C. parvum also increase NK cell activity (37, 56) . Newcastle disease virus, statolon, and polyinosinic acid-polycytidylic acid have been reported to enhance NK activity (13, 37) and protect against P. berghei (23) , and both mature NK cells (20) and protection against hemoprotozoa by BCG and Coxiella extract (8) (Fig. 3 and 6 ) are radioresistant. Finally, there is some evidence that NK cells secrete a nonspecific soluble inhibitor of deoxyribonucleic acid synthesis (41), which would be consistent with the intra-erythrocytic death of the parasites. Nevertheless, it is conceivable that contact between NK cells and parasitized erythrocytes, to the detriment of the parasite within, could protect in the absence of any detectable mediator. This contact could occur in the red pulp of the spleen.
We have earlier provided indirect evidence (8) that the final mediator may be the same in both BCG-induced protection and natural recovery. Thus, the involvement of interferon in natural recovery from these hemoprotozoa, perhaps acting via NK cells, warrants reappraisal. It provides, for instance, an alternative explanation for the temporary loss of control over protozoal parasites after either splenectomy or injection of corticosteroids. Both of these treatments can impair immunity to protozoa in the presence of stable amounts of specific antibody (12, 49, 55, 57) , which is inconsistent with the view that antibody acts alone to mediate protection (10, 42) . It may be relevant that mice recently splenectomized (22) or injected with corticosteroid (9) produce much less interferon after injection with endotoxin than do controls.
Similarly, there has been no explanation for reports that cells from the thoracic duct do not adoptively transfer protection against P. berghei in rats, whereas spleen cells are excellent for this purpose (45, 50) . This is again inconsistent with a mechanism wholly based on antibody, since thoracic duct lymphocytes of primarily immunized rats adoptively transfer the ability to respond to the same antigen with a secondarytype response (16) . Conceivably, most of the antigenic stimulation from a parasite restricted to the circulation could occur in the spleen. This should not prevent thoracic duct lymphocyte transfer of memory for antibody production, however, since splenic T cells, and to a lesser extent B cells, readily find their way into the thoracic duct within the collection period employed in the studies with P. berghei (48) . The explanation of these data (45, 50) may lie in the tissue distribution of NK cells; many are present in the spleen, but low or undetectable numbers are present in the thoracic ducts of rats (36) . Finally, the ability of serum from rats infected with P. berghei to control this parasite in the homologous host but not in mice (18) is more in keeping with the tendency of interferons to species specificity than with the broad spectrum of species activity shown by antibody.
Another non-antibody-soluble mediator, tumor necrosis factor (TNF), which is apparently different from interferon, has been reported to be released when BCG-, C. parvum-, or zymosan-treated mice received small doses of endotoxin (4). These workers attribute the nonspecific antitumor effect of these three agents to this mediator. It seems likely that other agents which cause macrophages to proliferate and form granulomas and cause hyperreactivity to endotoxin, accompanied by antitumor activity, may lead to release of TNF in the same circumstances. C. burnetii appears to fulfil these criteria (27, 43) (Table 1) . Whatever the mediator, a prerequisite for its formation seems, with all protectants, to be the presence of these granulomas in the liver and spleen. As well as TNF (4), endotoxin-induced interferon is reported to originate mainly from macrophages (47) .
Thus, both the interferon-NK cell system and TNF are under consideration as possible mediators of the protective effect of Coxiella extract against Babesia spp. and P. vinckei petteri. The species specificity reported for the humoral protective activity against P. berghei in rats (18) 
